Work

A Large Retrospective Analysis of the Activity of Pemetrexed (PEM) in Patients (Patients) with ALK+ NSCLC Before Crizotinib (CRIZ)

Year: 2012

Type: article

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)32007-x

Authors: G.V. Scagliotti, D.-W. Kim, A.T. Shaw, S.-H.I. Ou, G.J. Riely, S.N. Gettinger, B. Besse, M. Thomas, R. Salgia, K. Wilner, C.H. Bartlett, A. Polli, D.R. Gandara

Institutions: University of Turin, Seoul National University Hospital, Massachusetts General Hospital, University of California, Irvine, Memorial Sloan Kettering Cancer Center, Yale University, Institut Gustave Roussy, University of Chicago, Pfizer (United States), UC Davis Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2999084153

FWCI:

Cites:

Cited by:

Related to: 10